Literature DB >> 24907116

Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator.

Fraser M Rogerson1, Yi-Zhou Yao1, Morag J Young1, Peter J Fuller2.   

Abstract

The mineralocorticoid receptor (MR) is unique in responding to 2 physiological ligands: aldosterone and cortisol. In epithelial tissues, aldosterone selectivity is determined by the activity of 11β-hydroxysteroid dehydrogenase type 2. In other tissues, cortisol is the primary ligand. To understand the structural determinants of ligand-specific MR activation, we sought to identify coregulatory molecules that interact with the ligand-binding domain (LBD) of the MR. A yeast-2-hybrid (Y2H) kidney cDNA library was screened with the human MR-LBD in the presence of aldosterone and cortisol. One clone, identified as aldosterone-specific in the Y2H assay, exhibited a 7-fold greater response, aldosterone vs. cortisol, in a mammalian-2-hybrid (M2H) assay. This clone encodes the region of the tesmin gene that has 2 leucine-x-x-leucine-leucine (LxxLL) motifs. Full-length tesmin coactivates (>2-fold) MR-mediated transactivation in the presence of aldosterone, but not of cortisol; this specificity is observed with a range of promoters. GST pulldown and coimmunoprecipitation of the MR by tesmin supports a direct interaction, mediated by the 2 LxxLL motifs. Tesmin thus represents a novel MR coregulator that exhibits a differential interaction, providing further evidence of the adoption of ligand-dependent conformations by the MR-LBD. © FASEB.

Entities:  

Keywords:  aldosterone; cortisol; nuclear receptors

Mesh:

Substances:

Year:  2014        PMID: 24907116     DOI: 10.1096/fj.13-242479

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

Review 1.  Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.

Authors:  Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 2.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 3.  Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.

Authors:  Ana Maria Olivares; Oscar Andrés Moreno-Ramos; Neena B Haider
Journal:  J Exp Neurosci       Date:  2016-05-05

Review 4.  Glucocorticoid and Mineralocorticoid Receptors in the Brain: A Transcriptional Perspective.

Authors:  Anne-Sophie C A M Koning; Jacobus C Buurstede; Lisa T C M van Weert; Onno C Meijer
Journal:  J Endocr Soc       Date:  2019-07-24

5.  Role of tesmin expression in non-small cell lung cancer.

Authors:  Jedrzej Grzegrzolka; Mateusz Olbromski; Agnieszka Gomulkiewicz; Aleksandra Piotrowska; Natalia Glatzel-Plucinska; Katarzyna Ratajczak; Patrycja Sputa-Grzegrzolka; Adam Rzechonek; Bozena Werynska; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

Review 6.  Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective.

Authors:  Peter J Fuller; Yi-Zhou Yao; Jun Yang; Morag J Young
Journal:  J Hum Hypertens       Date:  2020-05-28       Impact factor: 3.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.